Carlsmed (CARL) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Carlsmed (CARL) do?
Carlsmed Inc (CARL) is a U.S.-listed company in Healthcare (Health Information Services). What it does: Creates custom spinal surgical plans and 3D-printed titanium implants using individual patient scan data. Uses patient scans and artificial intelligence to design and 3D-print personalized spinal fusion implants. It is worth $471.90M on the market and sold $71.83M over the last year.
- Market cap
- $471.90M
- P/E ratio
- None (reported a loss)
- Annual sales
- $71.83M
- Sector
- Healthcare
- Industry
- Health Information Services
- Brief updated
- Nov 19, 2026
Brands and businesses behind CARL
- aprevo: Personalized spine fusion implants and digital plans sold to hospitals for patient-specific spinal correction surgeries.
CARL’s flags, in plain English
Each flag is a number from Carlsmed’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.
Stupid Cash
Can pay this year's bills 5.8 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Wide Gross Margin
Gross margin of 77% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Insiders Hold
Insiders own 62.6% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.
Burning Cash
Losing money, profit margin of -55.8%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.
1 more green flag and 2 more risk notes open with the free trial. Try it free for 7 days.
Questions about CARL
How big is Carlsmed?
Carlsmed’s market cap is $471.90M: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $71.83M: what customers paid the company over the last year, before any costs.
What is CARL’s P/E ratio?
CARL has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with CARL?
Revenue depends heavily on the market adoption of a single core product family by spine surgeons. That is one risk on Carlsmed’s card. Its first risk flag is Burning Cash, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Carlsmed’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. CARL’s filings on SEC.gov. The Margin Monkey is research, not advice.
